Replies to post #103042 on Anavex Life Sciences Corp (AVXL)

[Batermere]

pianoguy, I was of the same sentiment as you are until recently. In the world of Baby Biotechs, the reality is that even if it's pretty good data all it will do is send the stock up with a short lived spike. It won't be sustained there, IMHO. The SHORTS and MARKET MANIPULATORS will drive it right back down. It's going to take something way more significant. I think that binary event will hopefully be FDA Approval for the treatment of Retts. I don't believe Wall St thinks much of AVXL right now and our novel approach. If we get that FDA Approval in our pocket then we could ascend into the $20s and never look back. I think we are going to be stuck in the $5-8 range until then. Patience will be rewarded.

[XenaLives]

The institutional holders don't have enough stock to become "activist" and that's the way we want to keep it.

If the lack of information continues, the institutional holders may consider abandoning ship or becoming activists in removing the good doctor

[Bourbon_on_my_cornflakes]

silly nonsense. the Tutes are just buying in now...because they like what they see. perfectly silly to say they are buying in now because they dont like the CEO....just silly

[A_Good_Day_2]

Continued releases of info on the 2a trial are not important. Continued good news is not going to help the pps. We need the next phase to start for that to happen. 2a completed already and the final results were astonishingly good. Now the trial has been extended beyond its originally intended length.

Actually, I believe that if they had the results already and they were bad, they would be obligated to share the results. The fact that they have decided not to update implies good results.

Any more data from the 2a is nice for making the case for approval earlier rather than later. Again, that would only matter once we are in ph 2/3.

[blu_1]

If your focus is share price, AVXL has done really well lately. The price was 2.43 last September and is 5.82 now. That's well over a 100% increase in only 7 months. Stock continues its uptrend.